Please confirm topic selection

Are you sure you want to trigger topic in your Anconeus AI algorithm?

Please confirm action

You are done for today with this topic.

Would you like to start learning session with this topic items scheduled for future?

Review Question - QID 100875

In scope icon M 1 E
QID 100875 (Type "100875" in App Search)
An 11-year-old boy with HIV and esophageal candidiasis is being treated with caspofungin. What is the mechanism of action of this drug?

Pore formation in cell membranes

8%

35/459

Inhibition of ergosterol synthesis

16%

74/459

Inhibition of squalene epoxidase

8%

36/459

Inhibition of pyrimidine synthesis

7%

33/459

Inhibition of 1,3-Beta-glucan synthase

53%

242/459

Select Answer to see Preferred Response

bookmode logo Review TC In New Tab

Caspofungin is an echinocandin that works by inhibiting 1,3-beta-glucan synthase, an enzyme that helps form the cell wall of fungi.

There are a variety of anti-fungal medications with different mechanisms of action. Echinocandins are a class of anti-fungal that work by inhibiting 1,3-beta-glucan synthase, an enzyme that is part of the pathway of beta-glucan synthesis. Beta-glucan is a an important part of the cell wall of certain medically relevant fungi (e.g. Aspergillus). There are only 3 Echinocandins approved by the FDA, caspofungin, micafungin, and anidulafungin (note that they all end in -fungin).

Mayr et al. review the mechanism of action and use of caspofungin. They note that it has an excellent safety profile and has good activity against a range of Candida species and is useful as an alternative therapy for aspergillus infections. They note that organisms resistant to caspofungin have been documented, but there is no clear pattern of factors contributing to caspofungin resistance.

Steinbach et al. enrolled 196 pediatric and 25 neonatal patients in an epidemiological survey of invasive candidiasis in hospitalized patients. They found that most of the infections had non-albicans Candida species as an etiology, and the most commonly used treatments were fluconazole, caspofungin, and liposomal amphotericin B for neonatal patients. For pediatric patients the most commonly prescribed anti-fungals were fluconazole, liposomal amphotericin B and micafungin. They noted that treatment outcomes for both pediatric and neonatal patients were similar regardless of drug class used.

Illustration A is a diagram of the mechanisms of action of several anti-fungals.
Illustration B is an endoscopy image of a patient with esophageal candidiasis.

Incorrect Answers:
Answer 1: Pore formation in cell membranes is the mechanism of action of Polyenes anti-fungals like amphotericin B and Nystatin.
Answer 2: Inhibition of ergosterol synthesis is the mechanism of action of azole anti-fungals (e.g. ketoconazole).
Answer 3: Inhibition of squalene epoxidase is the mechanism of action of Terbinafine.
Answer 4: Inhibition of pyrimidine synthesis is the mechanism of action of flucytosine.

ILLUSTRATIONS:
REFERENCES (2)
Authors
Rating
Please Rate Question Quality

4.3

  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon

(6)

Attach Treatment Poll
Treatment poll is required to gain more useful feedback from members.
Please enter Question Text
Please enter at least 2 unique options
Please enter at least 2 unique options
Please enter at least 2 unique options